| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
| SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
| BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
| DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| CDKAL1 |
Q5VV42
|
CDK5 regulatory subunit associated protein 1 like 1
|
|
1.6E-02 |
0.617 |
0.615 |
| CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
| GLIS3 |
Q8NEA6
|
GLIS family zinc finger 3
|
|
5.6E-08 |
0.590 |
0.654 |
| HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| PNKD |
Q8N490
|
PNKD metallo-beta-lactamase domain containing
|
|
4.1E-08 |
0.615 |
0.615 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RREB1 |
Q92766
|
ras responsive element binding protein 1
|
|
1.00 |
0.500 |
0.808 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |